Added to YB: 2023-10-09
Pitch date: 2023-10-09
RYZB:US [bullish]
RayzeBio, Inc.
+197.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
RayzeBio, Inc. operates as a biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.
Market Cap
$3.7B
Pitch Price
$21.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-7.13
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
RayzeBio, Inc. RYZB:US
A summary for this pitch has not been created yet.
Read full article (0 min)